Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours

Clinical Endocrinology

Volumn 56, Issue 3, 2002, Pages 281-290

  Haugen, Bryan R ^a   Woodmansee, Whitney W ^a   McDermott, Michael T ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; PROTEIN P53; PROTEIN RET; TELOMERASE; THYROID PEROXIDASE;

ACCURACY; ADULT; ASPIRATION BIOPSY; CASE REPORT; CYTOLOGY; CYTOPATHOLOGY; FEMALE; GENE REARRANGEMENT; HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK FACTOR; THYROID CARCINOMA; THYROID NODULE; THYROID TUMOR;

ADENOMA; ADULT; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036223980     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01500.x     Document Type: Review

References (73)

1. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid disease
2. Cancer risk in patients with cold thyroid nodules: Relevance of iodine intake, sex, age, and multinodularity
3. 'Suspicious' thyroid cytologic findings: Outcome in patients without immediate surgical treatment
4. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
5. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule
6. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer
7. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue
8. Identification of galectin-3 as a factor in pre-mRNA splicing
9. The value of thyroid peroxidase immunohistochemistry for preoperative fine-needle aspiration diagnosis of the follicular variant of papillary thyroid cancer
10. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues
11. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma
12. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas
13. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland
14. RET/PTC rearrangements in thyroid nodules: Studies in irradiated and not irradiated malignant and benign thyroid lesions in children and adults
15. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas
16. Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration
17. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue
18. Role of nuclear grooves in the diagnosis of papillary thyroid carcinoma
19. Cancer risks from germline p53 mutations
20. A new oncogene in human papillary thyroid carcinomas and their lymph-nodal metastases
21. Comparison of thyroid peroxidase expression with cellular proliferation in thyroid follicular tumors
22. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules
23. Nuclear p53 immunoreactivity in papillary thyroid cancers is associated with two established indicators of poor prognosis
24. Fine-needle aspiration biopsy of thyroid nodules. Advantages, limitations, and effect
25. Fine-needle aspiration biopsy of the thyroid: The problem of suspicious cytologic findings
26. Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis
27. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
28. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
29. The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds
30. Clinical implications of the p53 tumor-suppressor gene
31. Telomerase activity in benign and malignant thyroid tumors
32. Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules
33. The role of the p53 and Rb-1 genes in cancer, development and apoptosis
34. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion
35. Galectin-3 stimulates cell proliferation
36. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms
37. Genetic alterations in thyroid tumor progression: Association with p53 gene mutations
38. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland
39. The ret/PTC oncogene in papillary thyroid carcinoma
40. Telomerase activity and telomere length in benign and malignant human thyroid tissues
41. Pax8-PPAR gamma1 fusion oncogene in human thyroid carcinoma
42. Cancer. p53, guardian of the genome
43. Telomerase activity in thyroid malignancy
44. How p53 suppresses cell growth
45. Clinical implications of telomerase detection
46. Management of a solitary thyroid nodule
47. Apoptosis in thyroid neoplasms: Relationship with p53 and bcl-2 expression
48. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas
49. Galectin-3 induces endothelial cell morphogenesis and angiogenesis
50. Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer
51. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues
52. p53 and p21 (WAF1) expression in lymphocytic thyroiditis and thyroid tumors
53. Galectin-3 is a presurgical marker of human thyroid carcinoma
54. Quantitative cytology and thyroperoxidase immunochemistry: New tools in evaluating thyroid nodules by fine-needle aspiration
55. bcl-2, 53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas
56. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: Results of a prospective study of one hundred twenty patients
57. Endogenous galactoside-binding lectins: A new class of functional tumor cell surface molecules related to metastasis
58. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis
59. Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma
60. User of fine-needle aspiration biopsy and frozen section in the management of the solitary thyroid nodule
61. Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid
62. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms
63. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid
64. Distinct multiple ret/PTC gene rearrangements in multifocal papillary thyroid neoplasia
65. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA
66. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: Strong suppression of peroxidase gene expression
67. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration
68. Telomerase activity: A marker to distinguish follicular thyroid adenoma from carcinoma
69. Immunohistochemical studies on thyroid peroxidase and thyroglobulin in 13 human thyroid tumors and 7 Graves' goiters
70. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications
71. Telomerase activity in benign and malignant thyroid diseases
72. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells
73. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms